IBDEI0T5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14106,1,3,0)
 ;;=3^735.8
 ;;^UTILITY(U,$J,358.3,14106,1,5,0)
 ;;=5^Mallet Toe; Acquired
 ;;^UTILITY(U,$J,358.3,14106,2)
 ;;=^272714
 ;;^UTILITY(U,$J,358.3,14107,0)
 ;;=755.66^^74^860^2
 ;;^UTILITY(U,$J,358.3,14107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14107,1,3,0)
 ;;=3^755.66
 ;;^UTILITY(U,$J,358.3,14107,1,5,0)
 ;;=5^Mallet toe; Congenital
 ;;^UTILITY(U,$J,358.3,14107,2)
 ;;=^273059
 ;;^UTILITY(U,$J,358.3,14108,0)
 ;;=736.70^^74^860^3
 ;;^UTILITY(U,$J,358.3,14108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14108,1,3,0)
 ;;=3^736.70
 ;;^UTILITY(U,$J,358.3,14108,1,5,0)
 ;;=5^Metatarsal deformity; Acquired
 ;;^UTILITY(U,$J,358.3,14108,2)
 ;;=^123805
 ;;^UTILITY(U,$J,358.3,14109,0)
 ;;=754.70^^74^860^4
 ;;^UTILITY(U,$J,358.3,14109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14109,1,3,0)
 ;;=3^754.70
 ;;^UTILITY(U,$J,358.3,14109,1,5,0)
 ;;=5^Metatarsal deformity; Congenital
 ;;^UTILITY(U,$J,358.3,14109,2)
 ;;=^25440
 ;;^UTILITY(U,$J,358.3,14110,0)
 ;;=726.70^^74^860^5
 ;;^UTILITY(U,$J,358.3,14110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14110,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,14110,1,5,0)
 ;;=5^Metatarsalgia
 ;;^UTILITY(U,$J,358.3,14110,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,14111,0)
 ;;=355.6^^74^860^10
 ;;^UTILITY(U,$J,358.3,14111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14111,1,3,0)
 ;;=3^355.6
 ;;^UTILITY(U,$J,358.3,14111,1,5,0)
 ;;=5^Morton's metatarsalgia, neuralgia, or neuroma
 ;;^UTILITY(U,$J,358.3,14111,2)
 ;;=               ^268517
 ;;^UTILITY(U,$J,358.3,14112,0)
 ;;=736.79^^74^860^7
 ;;^UTILITY(U,$J,358.3,14112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14112,1,3,0)
 ;;=3^736.79
 ;;^UTILITY(U,$J,358.3,14112,1,5,0)
 ;;=5^Metatarsal adductus/varus; Acquired
 ;;^UTILITY(U,$J,358.3,14112,2)
 ;;=^272742
 ;;^UTILITY(U,$J,358.3,14113,0)
 ;;=754.53^^74^860^8
 ;;^UTILITY(U,$J,358.3,14113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14113,1,3,0)
 ;;=3^754.53
 ;;^UTILITY(U,$J,358.3,14113,1,5,0)
 ;;=5^Metatarsal adductus/varus; Congenital
 ;;^UTILITY(U,$J,358.3,14113,2)
 ;;=^273007
 ;;^UTILITY(U,$J,358.3,14114,0)
 ;;=355.8^^74^860^9
 ;;^UTILITY(U,$J,358.3,14114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14114,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,14114,1,5,0)
 ;;=5^Mononeuritis of lower limb, unspecified
 ;;^UTILITY(U,$J,358.3,14114,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,14115,0)
 ;;=729.1^^74^860^11
 ;;^UTILITY(U,$J,358.3,14115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14115,1,3,0)
 ;;=3^729.1
 ;;^UTILITY(U,$J,358.3,14115,1,5,0)
 ;;=5^Myalgia and myositis, unspecified
 ;;^UTILITY(U,$J,358.3,14115,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,14116,0)
 ;;=355.71^^74^861^4
 ;;^UTILITY(U,$J,358.3,14116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14116,1,3,0)
 ;;=3^355.71
 ;;^UTILITY(U,$J,358.3,14116,1,5,0)
 ;;=5^Nerve entrapment, lower limb
 ;;^UTILITY(U,$J,358.3,14116,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,14117,0)
 ;;=216.7^^74^861^2
 ;;^UTILITY(U,$J,358.3,14117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14117,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,14117,1,5,0)
 ;;=5^Neoplasm, skin of lower limb, including hip; Benign
 ;;^UTILITY(U,$J,358.3,14117,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,14118,0)
 ;;=239.2^^74^861^3
 ;;^UTILITY(U,$J,358.3,14118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14118,1,3,0)
 ;;=3^239.2
 ;;^UTILITY(U,$J,358.3,14118,1,5,0)
 ;;=5^Neoplasm, skin, bone and soft tissue; Unspecified
 ;;^UTILITY(U,$J,358.3,14118,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,14119,0)
 ;;=356.9^^74^861^7
 ;;^UTILITY(U,$J,358.3,14119,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0T5
